NADP-dependent malic enzyme 4 (NADP-ME4) and glyceraldehyde-3-phosphate dehydrogenase (GAPC) were both found to be downregulated in MS; they are primarily involved in energy production and conversion. This evidence concerns the gene GAPDH and myeloid sarcoma.